223 related articles for article (PubMed ID: 19451623)
1. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.
Hauber I; Hohenberg H; Holstermann B; Hunstein W; Hauber J
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9033-8. PubMed ID: 19451623
[TBL] [Abstract][Full Text] [Related]
2. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC
J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.
Zhou RH; Guo L; Liu JB; Liu H; Hou W; Ma TC; Wang X; Wu JG; Ye L; Ho WZ; Li JL
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):232-240. PubMed ID: 28328549
[TBL] [Abstract][Full Text] [Related]
4. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
[TBL] [Abstract][Full Text] [Related]
5. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI).
Elias AK; Wilson MR; Carver JA; Musgrave IF
Cells; 2022 Oct; 11(20):. PubMed ID: 36291126
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ
J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984
[TBL] [Abstract][Full Text] [Related]
7. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
[TBL] [Abstract][Full Text] [Related]
8. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
[TBL] [Abstract][Full Text] [Related]
9. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
Elias AK; Scanlon D; Musgrave IF; Carver JA
Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.
Castellano LM; Hammond RM; Holmes VM; Weissman D; Shorter J
Biol Open; 2015 Aug; 4(9):1206-12. PubMed ID: 26319581
[TBL] [Abstract][Full Text] [Related]
11. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
[TBL] [Abstract][Full Text] [Related]
12. Semen-derived amyloid fibrils drastically enhance HIV infection.
Münch J; Rücker E; Ständker L; Adermann K; Goffinet C; Schindler M; Wildum S; Chinnadurai R; Rajan D; Specht A; Giménez-Gallego G; Sánchez PC; Fowler DM; Koulov A; Kelly JW; Mothes W; Grivel JC; Margolis L; Keppler OT; Forssmann WG; Kirchhoff F
Cell; 2007 Dec; 131(6):1059-71. PubMed ID: 18083097
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S
J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG.
Hartjen P; Frerk S; Hauber I; Matzat V; Thomssen A; Holstermann B; Hohenberg H; Schulze W; Schulze Zur Wiesch J; van Lunzen J
AIDS Res Ther; 2012 Jan; 9(1):2. PubMed ID: 22260499
[TBL] [Abstract][Full Text] [Related]
15. A molecular tweezer antagonizes seminal amyloids and HIV infection.
Lump E; Castellano LM; Meier C; Seeliger J; Erwin N; Sperlich B; Stürzel CM; Usmani S; Hammond RM; von Einem J; Gerold G; Kreppel F; Bravo-Rodriguez K; Pietschmann T; Holmes VM; Palesch D; Zirafi O; Weissman D; Sowislok A; Wettig B; Heid C; Kirchhoff F; Weil T; Klärner FG; Schrader T; Bitan G; Sanchez-Garcia E; Winter R; Shorter J; Münch J
Elife; 2015 Aug; 4():. PubMed ID: 26284498
[TBL] [Abstract][Full Text] [Related]
16. Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.
Nance CL; Siwak EB; Shearer WT
J Allergy Clin Immunol; 2009 Feb; 123(2):459-65. PubMed ID: 19203663
[TBL] [Abstract][Full Text] [Related]
17. [Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV].
Duan JM; Qiu JY; Tan SY; Liu SW; Li L
Bing Du Xue Bao; 2012 Jan; 28(1):84-8. PubMed ID: 22416356
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.
Castellano LM; Bart SM; Holmes VM; Weissman D; Shorter J
Chem Biol; 2015 Aug; 22(8):1074-86. PubMed ID: 26256479
[TBL] [Abstract][Full Text] [Related]
19. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
[TBL] [Abstract][Full Text] [Related]
20. Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).
Popovych N; Brender JR; Soong R; Vivekanandan S; Hartman K; Basrur V; Macdonald PM; Ramamoorthy A
J Phys Chem B; 2012 Mar; 116(11):3650-8. PubMed ID: 22360607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
